Dr. Andrew Singleton is an NIH distinguished investigator and has published more than 500 articles. His laboratory of ~50 staff members includes five principal investigators and three group leaders working on the genetic basis of neurological disorders. The goal of this research is to identify genetic variability that causes or contributes to disease and to use this knowledge to understand the molecular processes underlying disease. Dr. Singleton serves on the scientific advisory board of the Lewy Body Dementia Association and is a member of the editorial boards of nine journals. Dr. Singleton has been awarded the Boehringer Mannheim Research Award, the NIH Director’s Award, the Annemarie Opprecht Award for Parkinson’s Disease Research, the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research, the American Academy of Neurology Movement Disorders Award and an Honorary Doctorate from the University of Sunderland.